Donna Stegner

Head of Strategic Initiatives for Preclinical & Translational Sciences at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Donna Stegner's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Stacey Taraskiewicz

Head, Sponsor Oversight & Inspection Readiness

Contact Stacey Taraskiewicz

Sanjay Agrawal

Lead, Clinical Data Technology

Contact Sanjay Agrawal

Elizabeth Dritz

Head of Manufacturing, Biologics

Contact Elizabeth Dritz

Jennifer Valentine

Senior Marketing, Brand Lead, GI Rare

Contact Jennifer Valentine

Colleen Beauregard

Head, R&D Communications, Learning, Partnerships and Policy (CLPP)

Contact Colleen Beauregard

Edwin Barbarin

Head, Pharmacovigilance & Medical Quality

Contact Edwin Barbarin

Robert Cook

Head, Communications, Chief Medical Office

Contact Robert Cook

View All Donna Stegner's Colleagues
Donna Stegner's Contact Details
HQ
224-554-6500
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Takeda Pharmaceuticals (formerly Nycomed)
Donna Stegner's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Donna Stegner
Donna Stegner currently works for Takeda Pharmaceuticals (formerly Nycomed).
Donna Stegner's role at Takeda Pharmaceuticals (formerly Nycomed) is Head of Strategic Initiatives for Preclinical & Translational Sciences.
Donna Stegner's email address is ***@takeda.com. To view Donna Stegner's full email address, please signup to ConnectPlex.
Donna Stegner works in the Major Drugs industry.
Donna Stegner's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Stacey Taraskiewicz, Sanjay Agrawal, Elizabeth Dritz, Jennifer Valentine, Colleen Beauregard, Edwin Barbarin, Robert Cook and others.
Donna Stegner's phone number is 224-554-6500
See more information about Donna Stegner